Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
Clinical trial NCT02988440 · COMPLETED
Trial details
- NCT number
- NCT02988440
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2020-02-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.